4//SEC Filing
Rome Michael E 4
Accession 0001209191-22-037018
CIK 0001797768other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:00 PM ET
Size
5.5 KB
Accession
0001209191-22-037018
Insider Transaction Report
Form 4
Rome Michael E
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-13+20,250→ 20,250 totalExercise: $8.38Exp: 2032-06-13→ Common Stock (20,250 underlying)
Footnotes (1)
- [F1]1/12th of the shares underlying the Option vest and become exercisable on a monthly basis starting July 13, 2022 (the Vest Base Date) and thereafter on the same day of the month as the Vest Base Date or if earlier, the day immediately before the date of the next Annual Meeting of Stockholders that occurs after the Vest Base Date.
Documents
Issuer
Kinnate Biopharma Inc.
CIK 0001797768
Entity typeother
Related Parties
1- filerCIK 0001820818
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:00 PM ET
- Size
- 5.5 KB